Evidence map›Paper›PMID 37297192›Full record

ArticleMaterials (Basel, Switzerland)2023

Biogenic Fabrication of Silver Nanoparticles Using

Pooja V Nagime, Sudarshan Singh, Nishat M Shaikh, Komal S Gomare, Havagiray Chitme, Basel A Abdel-Wahab, Yahya S Alqahtany, Masood Medleri Khateeb, Mohammed Shafiuddin Habeeb, Marwa B Bakir

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Eco-Friendly Synthesis and Characterization ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Mechanistic insights intoJournal of advanced veterinary and animal research · 2025
    Article
  8. Reducing lead toxicity with advanced nanotechnology methods.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  9. Review
  10. Review
  11. AqueousNanomaterials (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Green Synthesis of Silver Nanoparticles fromPharmaceutical nanotechnology · 2025
    Article
  14. Green Synthesis of Silver Nanoparticles UsingCurrent pharmaceutical biotechnology · 2025
    Article
  15. Biogenic metallic nanoparticles: from green synthesis to clinical translation.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pooja V NagimeDepartment of Biotechnology, Dayanand Science College, Latur 413512, India.ORCID 0000-0002-3706-744X
Sudarshan SinghDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-7929-3322
Nishat M ShaikhDepartment of Biotechnology, Dayanand Science College, Latur 413512, India.
Komal S GomareDepartment of Biotechnology, Dayanand Science College, Latur 413512, India.
Havagiray ChitmeFaculty of Pharmacy, DIT University, Dehradun 248009, India.ORCID 0000-0002-4855-9634
Basel A Abdel-WahabDepartment of Pharmacology, College of Pharmacy, Najran University, Najran P.O. Box 1988, Saudi Arabia.ORCID 0000-0002-5545-6422
Yahya S AlqahtanyDepartment of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran P.O. Box 1988, Saudi Arabia.
Masood Medleri KhateebDepartment of Pharmacology, College of Pharmacy, Najran University, Najran P.O. Box 1988, Saudi Arabia.ORCID 0000-0003-0591-5210
Mohammed Shafiuddin HabeebDepartment of Pharmacology, College of Pharmacy, Najran University, Najran P.O. Box 1988, Saudi Arabia.
Marwa B BakirDepartment of Pharmacology, College of Medicine, Najran University, Najran P.O. Box 1988, Saudi Arabia.

Funding

Najran University NU/RG/MRC/12/13
6 · The paper itself

Abstract

There have been some reports demonstrating the biogenic synthesis of silver nanoparticles (AgNPs) using

Indexed as

antibacterialantidiabeticanti-inflammatoryantioxidantCalotropis procerasilver nanoparticles

Identifiers

PMID37297192
PMCPMC10254777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.